Z. Gordon Jiang

ORCID: 0000-0003-0495-9940
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Adenosine and Purinergic Signaling
  • Diet, Metabolism, and Disease
  • Alcohol Consumption and Health Effects
  • Liver Diseases and Immunity
  • Hepatitis C virus research
  • Lipid metabolism and disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Adolescent and Pediatric Healthcare
  • Endoplasmic Reticulum Stress and Disease
  • Proteins in Food Systems
  • Organ Transplantation Techniques and Outcomes
  • Colorectal Cancer Screening and Detection
  • Protein Structure and Dynamics
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Microtubule and mitosis dynamics
  • Pancreatic function and diabetes
  • Pancreatitis Pathology and Treatment
  • Peroxisome Proliferator-Activated Receptors
  • Lipid metabolism and biosynthesis
  • Microencapsulation and Drying Processes
  • Liver physiology and pathology

Beth Israel Deaconess Medical Center
2016-2025

Harvard University
2016-2025

Jiangnan University
2025

Northeast Agricultural University
2024-2025

Nanjing Forestry University
2025

Shanghai Academy of Agricultural Sciences
2024

Guilin Medical University
2024

Hadassah Medical Center
2024

Central South University
2020-2023

China Agricultural University
2021-2023

Background and Aims: A new term, metabolic dysfunction–associated steatotic liver disease (MASLD), has been proposed by a multi-society expert panel. However, it remains unclear whether hepatic steatosis per se in MASLD contributes to an increased risk of mortality individuals with any cardio-metabolic factor (CMRF), which is also significant for mortality. This study aimed compare all-cause cause-specific between the “MASLD/MetALD” “no (SLD)” groups CMRF. Approach Results: population-based...

10.1097/hep.0000000000000925 article EN Hepatology 2024-05-13

Summary Background Recent animal studies have shown that platelets directly activate hepatic stellate cells to promote liver fibrosis, whereas anti‐platelet agents decrease fibrosis. It is unknown whether platelet inhibition by aspirin prevents fibrosis in humans. Aim To examine the association between use and among adults with suspected chronic disease. Methods We conducted a cross‐sectional analysis using data from National Health Nutrition Examination Survey III . identified 1856...

10.1111/apt.13515 article EN Alimentary Pharmacology & Therapeutics 2016-01-07
Katy Börner Philip D. Blood Jonathan C. Silverstein Matthew Ruffalo Rahul Satija and 95 more Sarah A. Teichmann Gloria Pryhuber Ravi Misra Jeffrey M. Purkerson Jean Fan John W. Hickey Gesmira Molla Chuan Xu Yun Zhang Griffin M. Weber Yashvardhan Jain Danial Qaurooni Yongxin Kong Jakub Abramson David M. Anderson Kristin Ardlie Mark J. Arends Bruce J. Aronow Rachel Bajema Richard Baldock Ross Barnowski Daria Barwinska Amy Bernard David Betancur Supriya Bidanta Frida Björklund Axel Bolin Avinash Boppana Luke Boulter Kristen Browne Maigan A. Brusko Albert Burger Martha Campbell‐Thompson Ivan Cao-Berg Anita R. Caron Megan Carroll Chrystal Chadwick Hao Chen Lu Chen Bernard de Bono Gail Deutsch Song‐Lin Ding Sean P. Donahue Tarek M. El‐Achkar Adel Eskaros Louis D. Falo Melissa A. Farrow Michael J. Ferkowicz Stephen Fisher James C. Gee Ronald N. Germain Michael Ginda Fiona Ginty Sarah A. Gitomer Melanie B. Goldstone Katherine S. Gustilo James S. Hagood Marc K. Halushka Muzlifah Haniffa Peter Hanna Josef Hardi Yongqun He Brendan John Honick Derek Houghton Maxim Itkin Sanjay Jain Laura Jardine Z. Gordon Jiang Yingnan Ju Arivarasan Karunamurthy Neil L. Kelleher Timothy J. Kendall Angela Kruse Monica M. Laronda Louise C. Laurent Elisa Laurenti Sujin Lee Ed S. Lein Chenran Li Zhuoyan Li Shin Lin Yiing Lin Scott A. Lindsay Teri A. Longacre Emma Lundberg Libby Maier Rajeev Malhotra Anna Martinez Casals Anna Maria Masci Clayton E. Mathews Elizabeth McDonough James Alastair McLaughlin Rajasree Menon Vilas Menon Jeremy A. Miller

Abstract The Human BioMolecular Atlas Program (HuBMAP) aims to construct a 3D Reference (HRA) of the healthy adult body. Experts from 20+ consortia collaborate develop Common Coordinate Framework (CCF), knowledge graphs and tools that describe multiscale structure human body (from organs tissues down cells, genes biomarkers) use HRA characterize changes occur with aging, disease other perturbations. v.2.0 covers 4,499 unique anatomical structures, 1,195 cell types 2,089 biomarkers (such as...

10.1038/s41592-024-02563-5 article EN cc-by Nature Methods 2025-03-13

Hepatic assembly of triacylglycerol (TAG)-rich very low density lipoproteins (VLDL) is achieved through recruitment bulk TAG (presumably in the form lipid droplets within microsomal lumen) into VLDL precursor containing apolipoprotein (apo) B-100. We determined protein/lipid components lumenal (LLD) cells expressing recombinant human apoC-III (C3wt) or a mutant (K58E, C3KE) initially identified humans that displayed hypotriglyceridemia. Although expression C3wt markedly stimulated secretion...

10.1074/jbc.m110.203679 article EN cc-by Journal of Biological Chemistry 2011-06-16

BackgroundWhole-exome sequencing (WES) is an effective tool for diagnosis in patients who remain undiagnosed despite a comprehensive clinical work-up. While WES being used increasingly pediatrics and oncology, it remains underutilized non-oncological adult medicine, including with liver disease, part based on the faulty premise that adults are unlikely to harbor rare genetic variants large effect size. Here, we aim assess burden of underlying disease at two major tertiary referral academic...

10.1016/j.ebiom.2023.104747 article EN cc-by-nc-nd EBioMedicine 2023-08-09

We have shown that expression of apolipoprotein (apo) C-III promotes VLDL secretion from transfected McA-RH7777 cells under lipid-rich conditions. To determine structural elements within apoC-III confer to this function, we contrasted wild-type with a mutant Ala23Thr originally identified in hypotriglyceridemia subjects. Although synthesis [(3)H]glycerol-labeled TAG was comparable between expressing (C3wt cells) or (C3AT cells), [(3)H]TAG C3AT markedly decreased. The lowered associated an...

10.1194/jlr.m005108 article EN cc-by Journal of Lipid Research 2010-01-25

The aspartate-to-alanine aminotransferase ratio (AAR) is associated with liver fibrosis, but its predictive performance suboptimal. We hypothesized that the association between AAR and disease depends on absolute transaminase levels developed validated a model to predict liver-related outcomes in general population. A Cox regression based age, AAR, alanine (ALT) level (dynamic [dAAR]) using restricted cubic splines was Finnish population-based health-examination surveys (FINRISK, 2002-2012;...

10.1002/hep4.1700 article EN Hepatology Communications 2021-03-08

A major challenge in the management of nonalcoholic fatty liver disease (NAFLD) is to identify patients with steatohepatitis (NASH) and early fibrosis. The progression NAFLD accompanied by distinctive changes very low density lipoprotein (VLDL), a particle produced exclusively liver. Herein, we sought determine characteristics VLDL profiles associated NASH fibrosis.We evaluated 128 from single centre registry, examined size, total subclass concentrations relation activity score (NAS),...

10.1111/liv.13076 article EN Liver International 2016-01-27

Background Dyslipidemia, typically recognized as high serum triglyceride, low-density lipoprotein cholesterol (LDL-C) or low high-density (HDL-C) levels, are associated with nonalcoholic fatty liver disease (NAFLD). However, LDL-C levels could result from defects in metabolism impaired synthetic function, and may serve ab initio markers for unrecognized diseases. Whether such relationships exist the general population has not been investigated. We hypothesized that despite common conception...

10.1371/journal.pone.0085366 article EN cc-by PLoS ONE 2014-01-15

Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous driven by genetic and environmental factors. MicroRNAs (miRNAs) serve as pleiotropic post-transcriptional regulators of cellular pathways. Although several miRNAs have been associated with NAFLD fibrosis, there are limited studies in humans examining their differential association pathogenic factors or histological features NAFLD. We examined the relationships five best-described circulating microRNAs (miR-34a, miR-122, miR-191,...

10.1002/hep4.1501 article EN cc-by-nc-nd Hepatology Communications 2020-03-13

Introduction: Vitamin A, a fat-soluble vitamin that includes retinol and carotenoids, is implicated in liver fibrosis, whereas its deficiency has been associated with various diseases higher overall mortality. This study aims to determine the relationship between levels of A species as well liver-related mortality population US. Methods: total 12,299 participants from National Health Nutrition Examination Survey III (NHANES III) were analyzed provide nationally representative estimates...

10.1097/hc9.0000000000000124 article EN cc-by-nc-nd Hepatology Communications 2023-04-14

Background: Low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for cardiovascular disease, and it plays causal role in the development of atherosclerosis. Genome-wide association studies (GWASs) have successfully identified hundreds genetic variants associated with LDL-C. Most these loci fall non-coding regions genome, unclear how affect circulating lipid levels. One hypothesis that genetically mediated variation transcript abundance, detected via analysis...

10.3390/genes16010084 article EN Genes 2025-01-15
Coming Soon ...